Document Detail


Reperfusion therapies of acute ischemic stroke: potentials and failures.
MedLine Citation:
PMID:  25404927     Owner:  NLM     Status:  PubMed-not-MEDLINE    
Abstract/OtherAbstract:
Over the past 20 years, clinical research has focused on the development of reperfusion therapies for acute ischemic stroke (AIS), which include the use of systemic intravenous thrombolytics (alteplase, desmoteplase, or tenecteplase), the augmentation of systemic intravenous recanalization with ultrasound, the bridging of intravenous with intra-arterial thrombolysis, the use of multi-modal approaches to reperfusion including thrombectomy and thromboaspiration with different available retrievers. Clinical trials testing these acute reperfusion therapies provided novel insight regarding the comparative safety and efficacy, but also raised new questions and further uncertainty on the field. Intravenous alteplase (tPA) remains the fastest and easiest way to initiate acute stroke reperfusion treatment, and should continue to be the first-line treatment for patients with AIS within 4.5 h from onset. The use of tenecteplase instead of tPA and the augmentation of systemic thrombolysis with ultrasound are both novel therapeutical modalities that may emerge as significant options in AIS treatment. Endovascular treatments for AIS are rapidly evolving due to technological advances in catheter-based interventions and are currently emphasizing speed in order to result in timely restoration of perfusion of still-salvageable, infarcted brain tissue, since delayed recanalization of proximal intracranial occlusions has not been associated with improved clinical outcomes. Comprehensive imaging protocols in AIS may enable better patient selection for endovascular interventions and for testing multi-modal combinatory strategies.
Authors:
Georgios Tsivgoulis; Aristeidis H Katsanos; Andrei V Alexandrov
Related Documents :
3282887 - Cardiac nuclear medicine: positron emission tomography in clinical medicine.
20041907 - Image quality and myocardial scar size determined with magnetic resonance imaging in pa...
8644657 - Prognostic significance of normal dobutamine-atropine stress sestamibi scintigraphy in ...
10426327 - Dobutamine stress echocardiography and technetium-99m-tetrofosmin/fluorine 18-fluorodeo...
1619587 - Contingent and non-contingent biofeedback training for type a and b healthy adults: can...
2409627 - Clinical advantages of papaverine cardioplegia.
Publication Detail:
Type:  Journal Article; Review     Date:  2014-11-03
Journal Detail:
Title:  Frontiers in neurology     Volume:  5     ISSN:  1664-2295     ISO Abbreviation:  Front Neurol     Publication Date:  2014  
Date Detail:
Created Date:  2014-11-18     Completed Date:  2014-11-18     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101546899     Medline TA:  Front Neurol     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  215     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Some behavioral aspects of energy descent: how a biophysical psychology might help people transition...
Next Document:  Leptomeningeal metastases in high-grade adult glioma: development, diagnosis, management, and outcom...